Dosage form development, manufacture, and stability studies of NES-100 nasal spray
Ended Awarded Last action
- Contract number
- 75N95021F00003
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,986,960
Award facts
- Opportunity
-
- 75N95021R00049 Solicitation number
- Contract value 98% obligated
-
- $1,992,571.00 Current, with exercised options
- $2,028,306.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Funding Only Action | $5,611 | |
| Supplemental Agreement for work within scope | $0 | |
| Definitize Change Order | $18,989 | |
| Funding Only Action | $82,778 | |
| Original award | $1,879,582 |
About this award
This is a delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The $2,028,306.00 firm fixed-price contract is for dosage form development, manufacture, and stability studies of NES-100 nasal spray. The work is being performed under the NCATS Drug Product Development Studies 2017-2022 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. This contract does not have a set-aside designation and is expected to be completed by April 29, 2025. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business and for-profit limited liability company that specializes in pharmaceutical product development, manufacturing, and testing services for federal government agencies.
Quick answers
Who was awarded contract 75N95021F00003?
75N95021F00003 was awarded to Societal Cdmo San Diego, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2021.
How much is contract 75N95021F00003 worth?
The government has obligated $1,986,960 on 75N95021F00003. Its current value, with exercised options, is $1,992,571. Its potential value, with all options, is $2,028,306.
Which agency awarded contract 75N95021F00003?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00003, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95021F00003 an order under another contract?
Yes. 75N95021F00003 is a delivery order under HHSN271201700020I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N95021F00003 competed?
The extent of competition for 75N95021F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award